Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

OBJECTIVES: Biologic disease-modifying antirheumatic drugs (bDMARDs) have revolutionised treatment and outcomes for rheumatoid arthritis (RA). The expanding repertoire allows the option of switching bDMARD if current treatment is not effective. For some patients, even after switching, disease contro...

全面介紹

Na minha lista:
書目詳細資料
發表在:Ann Rheum Dis
Main Authors: Kearsley-Fleet, Lianne, Davies, Rebecca, De Cock, Diederik, Watson, Kath D, Lunt, Mark, Buch, Maya H, Isaacs, John D, Hyrich, Kimme L
格式: Artigo
語言:Inglês
出版: BMJ Publishing Group 2018
主題:
Clinical and Epidemiological Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6161665/
https://ncbi.nlm.nih.gov/pubmed/29980575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2018-213378
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍